| Title |
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial
|
|---|---|
| Published in |
Journal of Thrombosis and Thrombolysis, February 2019
|
| DOI | 10.1007/s11239-019-01823-y |
| Pubmed ID | |
| Authors |
Jeffrey B. Washam, Stefan H. Hohnloser, Renato D. Lopes, Daniel M. Wojdyla, Dragos Vinereanu, John H. Alexander, Bernard J. Gersh, Michael Hanna, John Horowitz, Elaine M. Hylek, Denis Xavier, Freek W. A. Verheugt, Lars Wallentin, Christopher B. Granger |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 43% |
| United States | 2 | 29% |
| Venezuela, Bolivarian Republic of | 1 | 14% |
| Unknown | 1 | 14% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Practitioners (doctors, other healthcare professionals) | 2 | 29% |
Mendeley readers
The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 78 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 12% |
| Student > Bachelor | 9 | 12% |
| Student > Postgraduate | 7 | 9% |
| Researcher | 7 | 9% |
| Other | 5 | 6% |
| Other | 15 | 19% |
| Unknown | 26 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 13% |
| Nursing and Health Professions | 5 | 6% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Business, Management and Accounting | 1 | 1% |
| Other | 4 | 5% |
| Unknown | 30 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2019.
All research outputs
#6,311,765
of 23,130,383 outputs
Outputs from Journal of Thrombosis and Thrombolysis
#258
of 996 outputs
Outputs of similar age
#120,065
of 352,934 outputs
Outputs of similar age from Journal of Thrombosis and Thrombolysis
#7
of 22 outputs
Altmetric has tracked 23,130,383 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 996 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,934 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.